# Clinical Reviewer Decision Record: Calculator Engines Owner Review & Internal ACC (EXT-C6-A)

**Identifier:** EXT-C6-A  
**Gate Category:** Final-Stage Human Gate (Clinical Reviewer / Product Owner)  
**Reviewer:** dr. Rizky Muhammad Asrizal (Medical Doctor & Owner, PanaceaMed)  
**Effective Date:** 2026-10-17 (re-affirmed 2026-11-02)  
**Governing Directive:** `governance/doctrine/PANACEA_C6_OWNER_ACC_DIRECTIVE.md`  
**Mapped Acceptance Criteria:** Legacy C6, Engineering V2 Clinical Review Phase Boundary  

---

## 1. Decision Question

> *Appoint a qualified reviewer and review each calculator engine per version (formula, parameters, population, limits, interpretation).*

---

## 2. Formal Clinical Review Determination

1. **Owner Clinical ACC Declaration:**
   - dr. Rizky Muhammad Asrizal, as licensed medical doctor and Product Owner, confirms personal examination and approval (ACC) of the 47 fundamental clinical calculator mathematical formulations, input boundary conditions, population constraints, and fail-closed physiological limit guards.
   - Engineering verification (independent references, hostile matrix testing, mutation sweeps, zero NaN tolerance) is 100% verified across the codebase (`scripts/qa/calculator-*.mts`).

2. **Phase Boundary & Clinical Use Restriction:**
   - This ACC represents the internal clinical review and engineering closure by the Product Owner for the Alpha phase.
   - It is **not** an external independent academic multi-center trial certification or an authorization for unverified autonomous patient treatment.
   - In the canonical repository ledger, external formal clinical validation remains properly classified in the subsequent Clinical Validation phase (`clinically_reviewed=false` remains in place until formal hospital deployment).

3. **Status:**
   - The clinical review requirement for engineering completion is formally satisfied by the Owner ACC.
   - Status: **DECIDED**.
